{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:09:00Z","timestamp":1790338140416,"version":"4.1.0"},"reference-count":195,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Ministry of University and Research","award":["2010JS3PMZ"],"award-info":[{"award-number":["2010JS3PMZ"]}]},{"name":"CARIPLO Biomedicine","award":["2011-0473"],"award-info":[{"award-number":["2011-0473"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vph.2015.09.003","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T21:38:25Z","timestamp":1442007505000},"page":"23-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"special_numbering":"C","title":["Oxidative stress in chronic vascular disease: From prediction to prevention"],"prefix":"10.1016","volume":"74","author":[{"given":"Francesca","family":"Santilli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"D'Ardes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Dav\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2015.09.003_bb0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tips.2013.03.007","article-title":"Oxidative stress in vascular disease and its pharmacological prevention","volume":"34","author":"Li","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.vph.2015.09.003_bb0010","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jacc.2010.03.092","article-title":"Isoprostane, an \u201cintermediate phenotype\u201d for oxidative stress heritability, risk trait associations, and the influence of chromogranin B polymorphism","volume":"56","author":"Rao","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2015.09.003_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2015.04.002","article-title":"Angiotensin type 1 receptor mediates chronic ethanol consumption-induced hypertension and vascular oxidative stress","author":"Passaglia","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2015.09.003_bb0020","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/nm.2005","article-title":"NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury","volume":"15","author":"Hecker","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0025","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/CIRCULATIONAHA.107.704155","article-title":"Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation","volume":"116","author":"Antoniades","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.09.003_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.110.985150","article-title":"Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling","volume":"124","author":"Antoniades","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.09.003_bb0035","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1161\/CIRCULATIONAHA.111.038919","article-title":"Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease","volume":"125","author":"Cunnington","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.09.003_bb0040","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/CIRCULATIONAHA.106.679084","article-title":"Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease","volume":"115","author":"Shirodaria","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.09.003_bb0045","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/ATVBAHA.109.198622","article-title":"Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia","volume":"30","author":"Pignatelli","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2015.09.003_bb0050","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1089\/ars.2013.5790","article-title":"Clinical application of NOX activity and other oxidative biomarkers in cardiovascular disease: a critical review","volume":"23","author":"Violi","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.vph.2015.09.003_bb0055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/2048872613504698","article-title":"Patients with microvascular obstruction after primary percutaneous coronary intervention show a gp91phox (NOX2) mediated persistent oxidative stress after reperfusion","volume":"2","author":"Niccoli","year":"2013","journal-title":"Eur Heart J Acute Cardiovasc. Care"},{"key":"10.1016\/j.vph.2015.09.003_bb0060","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jpeds.2012.05.042","article-title":"Obesity and hypercholesterolemia are associated with NOX2 generated oxidative stress and arterial dysfunction","volume":"161","author":"Loffredo","year":"2012","journal-title":"J. Pediatr."},{"key":"10.1016\/j.vph.2015.09.003_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11739-011-0591-x","article-title":"Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome","volume":"7","author":"Angelico","year":"2012","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0070","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000369981","article-title":"Continuous metabolic syndrome score is associated with specific biomarkers of inflammation and CVD risk in prepubertal children","volume":"66","author":"Olza","year":"2015","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.vph.2015.09.003_bb0075","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1185\/03007995.2012.717527","article-title":"Evaluation of emerging biomarkers in cardiovascular risk stratification of hypertensive patients: a 2-year study","volume":"28","author":"Derosa","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.vph.2015.09.003_bb0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2011.10.009","article-title":"Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina","volume":"413","author":"Tretjakovs","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.vph.2015.09.003_bb0085","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.2337\/dc12-0614","article-title":"Myeloperoxidase is an early biomarker of inflammation and cardiovascular risk in prepubertal obese children","volume":"35","author":"Olza","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vph.2015.09.003_bb0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.atherosclerosis.2013.11.075","article-title":"Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound","volume":"232","author":"Kataoka","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2015.09.003_bb0095","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/15257770802138558","article-title":"Uric acid: the oxidant\u2013antioxidant paradox","volume":"27","author":"Sautin","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.vph.2015.09.003_bb0100","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971\u20131992. National Health and Nutrition Examination Survey","volume":"283","author":"Fang","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vph.2015.09.003_bb0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.15171\/jcvtr.2014.004","article-title":"Serum uric acid predicts declining of circulating proangiogenic mononuclear progenitor cells in chronic heart failure patients","volume":"6","author":"Berezin","year":"2014","journal-title":"J. Cardiovasc. Thorac. Res."},{"key":"10.1016\/j.vph.2015.09.003_bb0110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/01.RES.87.5.349","article-title":"Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E)","volume":"87","author":"Carr","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2015.09.003_bb0115","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/0960327109358267","article-title":"Vitamin C prevents DNA damage induced by renovascular hypertension in multiple organs of Wistar rats","volume":"29","author":"Nishi","year":"2010","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.vph.2015.09.003_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.autneu.2010.07.025","article-title":"Acute superoxide scavenging restores depressed baroreflex sensitivity in renovascular hypertensive rats","volume":"159","author":"Botelho-Ono","year":"2011","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.vph.2015.09.003_bb0125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3945\/ajcn.112.035022","article-title":"Effect of acute administration of vitamin C on muscle sympathetic activity, cardiac sympathovagal balance, and baroreflex sensitivity in hypertensive patients","volume":"96","author":"Bruno","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.vph.2015.09.003_bb0130","first-page":"203179","article-title":"Postoperative atrial fibrillation","author":"Chelazzi","year":"2011","journal-title":"ISRN Cardiol."},{"key":"10.1016\/j.vph.2015.09.003_bb0135","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1089\/ars.2013.5205","article-title":"Role of vitamin C in the function of the vascular endothelium","volume":"19","author":"May","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.vph.2015.09.003_bb0140","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1017\/S0007114515000227","article-title":"Effect of vitamin C and vitamin E supplementation on endothelial function: a systematic review and meta-analysis of randomised controlled trials","volume":"113","author":"Ashor","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.vph.2015.09.003_bb0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/obr.12114","article-title":"Effect of antioxidant vitamin supplementation on endothelial function in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Montero","year":"2014","journal-title":"Obes. Rev."},{"key":"10.1016\/j.vph.2015.09.003_bb0150","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3945\/an.114.006254","article-title":"Vitamin E inadequacy in humans: causes and consequences","volume":"5","author":"Traber","year":"2014","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.vph.2015.09.003_bb0155","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.freeradbiomed.2014.02.017","article-title":"Effects of vitamin E on peroxisome proliferator-activated receptor \u03b3 and nuclear factor-erythroid 2-related factor 2 in hypercholesterolemia-induced atherosclerosis","volume":"70","author":"Bozaykut","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0160","first-page":"379","article-title":"Vitamin E supplementation may ameliorate oxidative stress in type 1 diabetes mellitus patients","volume":"57","author":"Gupta","year":"2011","journal-title":"Clin. Lab."},{"key":"10.1016\/j.vph.2015.09.003_bb0165","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1001\/jama.2008.600","article-title":"Vitamins E and C in the prevention of cardiovascular disease in men: the physicians' health study II randomized trial","volume":"300","author":"Sesso","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2015.09.003_bb0170","doi-asserted-by":"crossref","first-page":"f10","DOI":"10.1136\/bmj.f10","article-title":"Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials","volume":"346","author":"Myung","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.vph.2015.09.003_bb0175","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1096\/fasebj.13.9.977","article-title":"Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement","volume":"13","author":"Upston","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.vph.2015.09.003_bb0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2013.03.022","article-title":"Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence","volume":"66","author":"Niki","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0185","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.bcp.2010.07.043","article-title":"Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases","volume":"80","author":"Aggarwal","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.vph.2015.09.003_bb0190","first-page":"150829","article-title":"Tocotrienol rich palm oil extract is more effective than pure tocotrienols at improving endothelium-dependent relaxation in the presence of oxidative stress","author":"Ali","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.vph.2015.09.003_bb0195","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/01.ATV.0000149143.04821.eb","article-title":"ATVB in focus: redox mechanisms in blood vessels","volume":"25","author":"Mueller","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2015.09.003_bb0200","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMoa030535","article-title":"Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease","volume":"349","author":"Blankenberg","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0205","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase","volume":"101","author":"Aviram","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2015.09.003_bb0210","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0891-5849(00)00232-X","article-title":"Indices of lipid peroxidation in vivo: strenghts and limitations","volume":"28","author":"Meagher","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0215","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.clinbiochem.2010.07.022","article-title":"Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia","volume":"43","author":"Pirinccioglu","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.vph.2015.09.003_bb0220","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/08037051.2010.484158","article-title":"Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis","volume":"19","author":"Viigimaa","year":"2010","journal-title":"Blood Press."},{"key":"10.1016\/j.vph.2015.09.003_bb0225","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2174\/092986709787581888","article-title":"Soluble forms of RAGE in human diseases: clinical and therapeutical implications","volume":"16","author":"Santilli","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.vph.2015.09.003_bb0230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1467-789X.2011.00930.x","article-title":"Platelet activation in obesity and metabolic syndrome","volume":"13","author":"Santilli","year":"2012","journal-title":"Obes. Rev."},{"key":"10.1016\/j.vph.2015.09.003_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2015.04.004","article-title":"Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet\/coagulative activation identify non-alcoholic fatty liver disease among patients with Familial Combined Hyperlipidemia and\/or Metabolic syndrome","author":"Santilli","year":"2015","journal-title":"Vasc Pharm"},{"key":"10.1016\/j.vph.2015.09.003_bb0240","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4149\/neo_2015_061","article-title":"RAGE and its ligands in cancer \u2014 culprits, biomarkers, or therapeutic targets?","volume":"62","author":"Tesarova","year":"2015","journal-title":"Neoplasma"},{"key":"10.1016\/j.vph.2015.09.003_bb0245","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.freeradbiomed.2007.06.017","article-title":"Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins","volume":"43","author":"Santilli","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0250","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1210\/jc.2012-1473","article-title":"Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress","volume":"97","author":"Vazzana","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.vph.2015.09.003_bb0255","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1160\/TH13-04-0295","article-title":"Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE\/RAGE axis","volume":"110","author":"Santilli","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2015.09.003_bb0260","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/eurheartj\/eht402","article-title":"Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype","volume":"35","author":"Hanssen","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2015.09.003_bb0265","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1191\/0961203305lu2216oa","article-title":"Oxidant stress, inflammation and atherogenesis","volume":"14","author":"Dav\u00ec","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.vph.2015.09.003_bb0270","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.chemphyslip.2003.10.001","article-title":"Determinants of F2-isoprostane biosynthesis and inhibition in man","volume":"128","author":"Dav\u00ec","year":"2004","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.vph.2015.09.003_bb0275","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.freeradbiomed.2010.11.023","article-title":"F-2 isoprostanes as an indicator and risk factor for coronary heart disease","volume":"50","author":"Davies","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0280","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0891-5849(99)00264-6","article-title":"Measurement of F2-isoprostanes as an index of oxidative stress in vivo","volume":"28","author":"Roberts","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0285","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.99.2.224","article-title":"In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation","volume":"99","author":"Dav\u00ec","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.09.003_bb0290","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1161\/01.CIR.0000074205.17807.D0","article-title":"Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration","volume":"107","author":"Dav\u00ec","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.09.003_bb0295","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/01.CIR.102.5.539","article-title":"Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers","volume":"102","author":"Patrignani","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.09.003_bb0300","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.freeradbiomed.2012.02.012","article-title":"Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients","volume":"52","author":"Liani","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0305","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2010.10.006","article-title":"Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia","volume":"214","author":"Puccetti","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2015.09.003_bb0310","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1160\/TH11-12-0899","article-title":"Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C\u2192T polymorphism","volume":"108","author":"Dragani","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2015.09.003_bb0315","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.coph.2004.11.003","article-title":"Isoprostane formation and inhibition in atherothrombosis","volume":"5","author":"Patrono","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.vph.2015.09.003_bb0320","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.freeradbiomed.2009.01.005","article-title":"Determinants of platelet activation in hypertensives with microalbuminuria","volume":"46","author":"Guagnano","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0325","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.0000058402.34138.11","article-title":"Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study","volume":"23","author":"Keaney","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2015.09.003_bb0330","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.107.710509","article-title":"Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study","volume":"116","author":"Pou","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.09.003_bb0335","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2005.03.079","article-title":"Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus","volume":"47","author":"Santilli","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2015.09.003_bb0340","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.288.16.2008","article-title":"Platelet activation in obese women: role of inflammation and oxidant stress","volume":"288","author":"Dav\u00ec","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2015.09.003_bb0345","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.2174\/092986711798184299","article-title":"Determinants of increased cardiovascular disease in obesity and metabolic syndrome","volume":"18","author":"Vazzana","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.vph.2015.09.003_bb0350","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.freeradbiomed.2012.08.574","article-title":"Dietary patterns are associated with plasma F\u2082-isoprostanes in an observational cohort study of adults","volume":"57","author":"Meyer","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0355","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.96.1.69","article-title":"Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease","volume":"96","author":"Dav\u00ec","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.09.003_bb0360","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0049-3848(82)90254-7","article-title":"Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics","volume":"26","author":"Dav\u00ec","year":"1982","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2015.09.003_bb0365","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjcard.2009.04.047","article-title":"Usefulness of elevations in serum choline and free F2-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome","volume":"104","author":"LeLeiko","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.vph.2015.09.003_bb0370","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jacl.2008.06.004","article-title":"High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women","volume":"2","author":"Roest","year":"2008","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.vph.2015.09.003_bb0375","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1160\/TH14-07-0571","article-title":"Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation","volume":"113","author":"Pignatelli","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2015.09.003_bb0380","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1161\/01.ATV.17.11.2309","article-title":"Isoprostane: potential markers of oxidant stress in atherothrombotic disease","volume":"17","author":"Patrono","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2015.09.003_bb0385","article-title":"Lin CL. Cerebrospinal fluid biomarkers for neuropsychological symptoms in early stage of late-onset Alzheimer's disease","author":"Kuo","year":"2014","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.vph.2015.09.003_bb0390","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3945\/ajcn.112.051284","article-title":"Gastric cancer in Zambian adults: a prospective case-control study that assessed dietary intake and antioxidant status by using urinary isoprostane excretion","volume":"97","author":"Asombang","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.vph.2015.09.003_bb0395","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1158\/1055-9965.EPI-13-0619","article-title":"Oxidative balance score, colorectal adenoma, and markers of oxidative stress and inflammation","volume":"23","author":"Kong","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.vph.2015.09.003_bb0400","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11739-010-0440-3","article-title":"TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus","volume":"6","author":"Santilli","year":"2011","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0405","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijcard.2010.09.093","article-title":"Simvastatin administration reduces thromboxane production in subjects taking aspirin: links between aspirin resistance and thrombin generation","volume":"154","author":"Undas","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.vph.2015.09.003_bb0410","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1538-7836.2010.03820.x","article-title":"Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment","volume":"8","author":"Santilli","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2015.09.003_bb0415","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0420","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1111\/bph.12677","article-title":"Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation","volume":"171","author":"Bauer","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2015.09.003_bb0425","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2014.12.010","article-title":"Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus","volume":"80","author":"Santilli","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0430","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/j.1538-7836.2010.04117.x","article-title":"Redox-generated isoprostanes are associated with residual platelet activity in aspirin treated patients with stable coronary heart disease","volume":"8","author":"Schwedhelm","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2015.09.003_bb0435","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/09537100500441101","article-title":"Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX)1\/2, a novel COX-1 polymorphism or the PlA(1\/2) polymorphism","volume":"17","author":"Kranzhofer","year":"2006","journal-title":"Platelets"},{"key":"10.1016\/j.vph.2015.09.003_bb0440","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.thromres.2012.03.025","article-title":"Aspirinin sensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus","volume":"30","author":"Ames","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2015.09.003_bb0445","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000903","article-title":"Circulating myeloid-related protein-8\/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment","volume":"3","author":"Santilli","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.vph.2015.09.003_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2015.03.010","article-title":"Nox-2 up-regulation and platelet activation: novel insights","author":"Pastori","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.vph.2015.09.003_bb0455","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/db11-1243","article-title":"Platelet isoprostane overproduction in diabetic patients treated with aspirin","volume":"61","author":"Cangemi","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.vph.2015.09.003_bb0460","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1538-7836.2011.04558.x","article-title":"Dark chocolate inhibits platelet isoprostanes via NOX2 down-regulation in smokers","volume":"10","author":"Carnevale","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2015.09.003_bb0465","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/01.CIR.100.21.2131","article-title":"Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men","volume":"100","author":"Nickenig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.09.003_bb0470","doi-asserted-by":"crossref","first-page":"H750","DOI":"10.1152\/ajpheart.00029.2002","article-title":"Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ","volume":"283","author":"Stepp","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2015.09.003_bb0475","doi-asserted-by":"crossref","first-page":"13032","DOI":"10.1073\/pnas.0405292101","article-title":"The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport","volume":"101","author":"Bergt","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.vph.2015.09.003_bb0480","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0485","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.numecd.2005.11.012","article-title":"Endothelial dysfunction and oxidative stress in arterial hypertension","volume":"16","author":"Ferroni","year":"2006","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.vph.2015.09.003_bb0490","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1172\/JCI200314172","article-title":"Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension","volume":"111","author":"Landmesser","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2015.09.003_bb0495","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1073\/pnas.91.3.1044","article-title":"Superoxide and peroxynitrite in atherosclerosis","volume":"91","author":"White","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2015.09.003_bb0500","first-page":"409","article-title":"The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid","volume":"64","author":"Korbecki","year":"2013","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.vph.2015.09.003_bb0505","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.HYP.0000138070.47616.9d","article-title":"Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?","volume":"44","author":"Touyz","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2015.09.003_bb0510","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1586\/erc.09.127","article-title":"Recent changes in the landscape of combination RAS blockade","volume":"7","author":"Epstein","year":"2009","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.vph.2015.09.003_bb0515","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1590\/S0100-879X2004000800018","article-title":"Reactive oxygen species and angiotensin II signaling in vascular cells \u2013 implications in cardiovascular disease","volume":"37","author":"Touyz","year":"2004","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.vph.2015.09.003_bb0520","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0031-6997(24)01471-6","article-title":"Signal transduction mechanisms mediating the physiological and patho-physiological actions of angiotensin II in vascular smooth muscle cells","volume":"52","author":"Touyz","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.vph.2015.09.003_bb0525","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/01.CIR.73.4.628","article-title":"The relationships between alcoholic beverage use and other trials to blood pressure: a new Kaiser Permanente study","volume":"73","author":"Klatsky","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.09.003_bb0530","first-page":"525","article-title":"L'alcolisme cause d'hipertension arterielle","volume":"74","author":"Lian","year":"1915","journal-title":"Bull. Acad. Natl Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0535","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4330\/wjc.v6.i5.283","article-title":"Hypertension and chronic ethanol consumption: what do we know after a century of study?","volume":"6","author":"Marchi","year":"2014","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.vph.2015.09.003_bb0540","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/alcalc\/agq028","article-title":"Vascular actions of nitric oxide as affected by exposure to alcohol","volume":"45","author":"Toda","year":"2010","journal-title":"Alcohol"},{"key":"10.1016\/j.vph.2015.09.003_bb0545","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/157340211004150319122736","article-title":"Vascular oxidative stress: a key factor in the development of hypertension associated with ethanol consumption","volume":"10","author":"Ceron","year":"2014","journal-title":"Curr. Hypertens. Rev."},{"key":"10.1016\/j.vph.2015.09.003_bb0550","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jjcc.2013.06.003","article-title":"Ethanol promotes rat aortic vascular smooth muscle cell proliferation via increase of homocysteine and oxidized-low-density lipoprotein","volume":"62","author":"Shirpoor","year":"2013","journal-title":"J. Cardiol."},{"key":"10.1016\/j.vph.2015.09.003_bb0555","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.alcohol.2014.12.001","article-title":"Ethanol withdrawal increases oxidative stress and reduces nitric oxide bioavailability in the vasculature of rats","volume":"49","author":"Gonzaga","year":"2015","journal-title":"Alcohol"},{"key":"10.1016\/j.vph.2015.09.003_bb0560","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/0960327110384520","article-title":"Chronic ethanol ingestion induces aortic inflammation\/oxidative endothelial injury and hypertension in rats","volume":"30","author":"Husain","year":"2011","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.vph.2015.09.003_bb0565","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1211\/jpp.60.3.0008","article-title":"Ethanol consumption increases blood pressure and alters the responsiveness of the mesenteric vasculature in rats","volume":"60","author":"Tirapelli","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.vph.2015.09.003_bb0570","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.taap.2014.08.012","article-title":"Cardiovascular alterations at different stages of hypertension development during ethanol consumption: time-course of vascular and autonomic changes","volume":"280","author":"Crestani","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.vph.2015.09.003_bb0575","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11010-007-9583-6","article-title":"Chronic alcohol-induced oxidative endothelial injury relates to angiotensin II levels in the rat","volume":"307","author":"Husain","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.vph.2015.09.003_bb0580","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3109\/10253890.2014.966262","article-title":"Endothelial AT\u2081 and AT\u2082 pathways in aortic responses to angiotensin II after stress and ethanol consumption in rats","volume":"17","author":"Baptista Rde","year":"2014","journal-title":"Stress"},{"key":"10.1016\/j.vph.2015.09.003_bb0585","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jcjd.2014.03.002","article-title":"The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus","volume":"39","author":"Aouacheri","year":"2015","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.vph.2015.09.003_bb0590","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4239\/wjd.v6.i2.326","article-title":"Role of oxidative stress in endothelial insulin resistance","volume":"6","author":"Paneni","year":"2015","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.vph.2015.09.003_bb0595","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/10715760802629588","article-title":"Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca(2+) homeostasis","volume":"43","author":"Belia","year":"2009","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.vph.2015.09.003_bb0600","first-page":"569654","article-title":"Orr AW Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes","author":"Funk","year":"2012","journal-title":"Int. J. Vasc. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0605","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.ATV.0000160342.20342.00","article-title":"Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men","volume":"25","author":"Falcone","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2015.09.003_bb0610","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1161\/01.CIR.0000051367.92927.07","article-title":"High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species","volume":"107","author":"Cosentino","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.09.003_bb0615","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1172\/JCI23354","article-title":"Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation","volume":"116","author":"Du","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2015.09.003_bb0620","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1210\/jc.2004-1283","article-title":"Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress","volume":"90","author":"Pagnin","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.vph.2015.09.003_bb0625","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2174\/157016112803520747","article-title":"p66 Shc as the engine of vascular aging","volume":"10","author":"Paneni","year":"2012","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2015.09.003_bb0630","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1073\/pnas.0609656104","article-title":"Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress","volume":"104","author":"Camici","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.vph.2015.09.003_bb0635","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tcm.2013.01.001","article-title":"Cross-talk between SIRT1 and p66Shc in vascular diseases","volume":"23","author":"Chen","year":"2013","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0640","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2013.03.089","article-title":"Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches","volume":"62","author":"Tousoulis","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2015.09.003_bb0645","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","article-title":"Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study","volume":"52","author":"Spranger","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.vph.2015.09.003_bb0650","article-title":"DNA Methylation and MicroRNA-Based Biomarkers for Risk of Type 2 Diabetes","author":"O'Connell","year":"2015","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.vph.2015.09.003_bb0655","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/epi.14.84","article-title":"Oxidative stress and DNA methylation regulation in the metabolic syndrome","volume":"7","author":"Yara","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.vph.2015.09.003_bb0660","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S2213-8587(15)00127-8","article-title":"Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study","volume":"3","author":"Chambers","year":"2015","journal-title":"Lancet Diabet. Endocrinol."},{"key":"10.1016\/j.vph.2015.09.003_bb0665","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fendo.2015.00043","article-title":"The potential use of DNA methylation biomarkers to identify risk and progression of type 2 diabetes","volume":"6","author":"Gillberg","year":"2015","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.vph.2015.09.003_bb0670","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.2337\/db13-1459","article-title":"Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes","volume":"63","author":"Nilsson","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.vph.2015.09.003_bb0675","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","article-title":"Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes","volume":"107","author":"Zampetaki","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2015.09.003_bb0680","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1111\/j.1538-7836.2010.04007.x","article-title":"Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis","volume":"8","author":"Shantsila","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2015.09.003_bb0685","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1160\/TH10-11-0712","article-title":"Involvement of microparticles in diabetic vascular complications","volume":"106","author":"Tsimerman","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2015.09.003_bb0690","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1751-7176.2012.00631.x","article-title":"Plasma endothelial microparticles and their correlation with the presence of hypertension and arterial stiffness in patients with type 2 diabetes","volume":"14","author":"Chen","year":"2012","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.vph.2015.09.003_bb0695","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2008.07.039","article-title":"Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT)","volume":"203","author":"Bernard","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2015.09.003_bb0700","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1089\/ars.2013.5205","article-title":"Role of vitamin C in the function of the vascular endothelium","volume":"19","author":"May","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.vph.2015.09.003_bb0705","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.freeradbiomed.2014.02.017","article-title":"Effects of vitamin E on peroxisome proliferator-activated receptor and nuclear factor-erythroid related factor 2 in hypercholesterolemia-induced atherosclerosis","volume":"70","author":"Bozaykut","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0710","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1203\/01.PDR.0000141990.12375.13","article-title":"Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy","volume":"56","author":"Chiarelli","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.vph.2015.09.003_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2015.03.005","article-title":"The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)","author":"Siti","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2015.09.003_bb0720","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.CIR.0000137822.39831.F1","article-title":"Nutrition Committee of the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Antioxidant vitamin supplements and cardiovascular disease","volume":"110","author":"Kris-Etherton","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.09.003_bb0725","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/jn\/138.2.344","article-title":"Both a- and b carotene, but not tocopherols and vitamin C, are inversely related to 15-year cardiovascular mortality in Dutch elderly men","volume":"138","author":"Buijsse","year":"2008","journal-title":"J. Nutr."},{"key":"10.1016\/j.vph.2015.09.003_bb0730","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3164\/jcbn.40.141","article-title":"Antihypertensive and antioxidant action of amlodipine and vitamin C in patients of essential hypertension","volume":"40","author":"Mahajan","year":"2007","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.vph.2015.09.003_bb0735","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/CS20070343","article-title":"Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension","volume":"114","author":"Rodrigo","year":"2008","journal-title":"Clin. Sci."},{"key":"10.1016\/j.vph.2015.09.003_bb0740","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0140-6736(03)13637-9","article-title":"Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials","volume":"361","author":"Vivekananthan","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2015.09.003_bb0745","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/archinte.164.14.1552","article-title":"Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease","volume":"164","author":"Eidelman","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0750","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/archinte.167.15.1610","article-title":"A randomized factorial trial of vitamins C, E, and beta-carotene in the secondary prevention of cardiovascular events in women: results from the women's antioxidant cardiovascular study (WACS)","volume":"167","author":"Cook","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0755","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0760","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jama.297.8.842","article-title":"Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis","volume":"297","author":"Bjelakovic","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2015.09.003_bb0765","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1089\/ars.2013.5302","article-title":"Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research","volume":"20","author":"Montezano","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.vph.2015.09.003_bb0770","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0775","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jama.285.9.1178","article-title":"Effects of vitamin E on lipid peroxidation in healthy persons","volume":"285","author":"Meagher","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2015.09.003_bb0780","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.freeradbiomed.2008.04.005","article-title":"The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level","volume":"45","author":"Block","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0785","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.freeradbiomed.2007.06.019","article-title":"The relationship between dose of vitamin E and suppression of oxidative stress in humans","volume":"43","author":"Roberts","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0790","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1755-5922.2010.00179.x","article-title":"Nutraceuticals in diabetes and metabolic syndrome","volume":"28","author":"Dav\u00ec","year":"2010","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.vph.2015.09.003_bb0795","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.ejcn.1602107","article-title":"Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease","volume":"59","author":"Hansen","year":"2005","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.vph.2015.09.003_bb0800","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0030-1248725","article-title":"Moderate red wine consumption and cardiovascular disease risk: beyond the \u201cFrench paradox\u201d","volume":"36","author":"Lippi","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.vph.2015.09.003_bb0805","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jnutbio.2010.07.004","article-title":"Effects of resveratrol and other wine polyphenols on vascular function: an update","volume":"22","author":"Gresele","year":"2011","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.vph.2015.09.003_bb0810","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.abb.2012.05.003","article-title":"Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer","volume":"527","author":"Scoditti","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.vph.2015.09.003_bb0815","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/CS20110679","article-title":"Red wine extract protects against oxidative-stress-induced endothelial senescence","volume":"123","author":"Botden","year":"2012","journal-title":"Clin. Sci."},{"key":"10.1016\/j.vph.2015.09.003_bb0820","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/alcalc\/ags086","article-title":"Effect of red wine consumption on biomarkers of oxidative stress","volume":"48","author":"Schrieks","year":"2013","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.vph.2015.09.003_bb0825","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-1-60761-411-1_22","article-title":"Characterization of the antioxidant properties of pentaerithrityl tetranitrate (PETN)-induction of the intrinsic antioxidative system heme oxygenase-1 (HO-1)","volume":"594","author":"Daiber","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.vph.2015.09.003_bb0830","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jacc.2009.05.066","article-title":"Nebivolol: the somewhat-different betaadrenergic receptor blocker","volume":"54","author":"Munzel","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2015.09.003_bb0835","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.hjh.0000160216.86597.ff","article-title":"Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation","volume":"23","author":"Fratta Pasini","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2015.09.003_bb0840","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tcm.2013.09.006","article-title":"Antioxidant and antiplatelet effects of atorvastatin by Nox2 inhibition","volume":"24","author":"Violi","year":"2014","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0845","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/meta.2003.50093","article-title":"An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress","volume":"52","author":"Bonnefont-Rousselot","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.vph.2015.09.003_bb0850","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/dmrr.794","article-title":"Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects","volume":"24","author":"Formoso","year":"2008","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.vph.2015.09.003_bb0855","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMcibr1409796","article-title":"The target of metformin in type 2 diabetes","volume":"371","author":"Ferrannini","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0860","article-title":"Metformin reduces hyper-reactivity of platelets from patients with polycystic ovary syndrome by improving mitochondrial integrity","volume":"114","author":"Randriamboavonjy","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2015.09.003_bb0865","doi-asserted-by":"crossref","first-page":"H599","DOI":"10.1152\/ajpheart.00101.2013","article-title":"Angiotensin receptor-mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin-resistant rats","volume":"305","author":"V\u00e1zquez-Medina","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2015.09.003_bb0870","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.2337\/diacare.28.7.1690","article-title":"Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy","volume":"28","author":"Chiarelli","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vph.2015.09.003_bb0875","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrd3403","article-title":"Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets","volume":"10","author":"Drummond","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.vph.2015.09.003_bb0880","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cardiores.2006.01.022","article-title":"Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation","volume":"71","author":"ten Freyhaus","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2015.09.003_bb0885","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1021\/jm100773e","article-title":"First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis","volume":"53","author":"Laleu","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.vph.2015.09.003_bb0890","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1021\/cb100219n","article-title":"A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells","volume":"5","author":"Gianni","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.vph.2015.09.003_bb0895","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001329","article-title":"Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice","volume":"3","author":"Stachowicz","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.vph.2015.09.003_bb0900","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00210-013-0922-8","article-title":"Alda\u20101 reduces cerebral ischemia\/reperfusion injury in rat through clearance of reactive aldehydes","volume":"387","author":"Fu","year":"2014","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.vph.2015.09.003_bb0905","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.redox.2015.04.008","article-title":"Protection against renal ischemia\u2013reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQ","volume":"5","author":"Dare","year":"2015","journal-title":"Redox Biology"},{"key":"10.1016\/j.vph.2015.09.003_bb0910","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1073\/pnas.0707493105","article-title":"MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1","volume":"105","author":"Harris","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2015.09.003_bb0915","doi-asserted-by":"crossref","first-page":"F1630","DOI":"10.1152\/ajprenal.00400.2011","article-title":"MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation","volume":"302","author":"Asgeirsd\u00f3ttir","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.vph.2015.09.003_bb0920","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/cvr\/cvr227","article-title":"MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1(+)\/Lin(\u2212) progenitor cells in ischaemia","volume":"92","author":"van Solingen","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2015.09.003_bb0925","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","article-title":"The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis","volume":"15","author":"Wang","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.vph.2015.09.003_bb0930","doi-asserted-by":"crossref","first-page":"497280","DOI":"10.1155\/2015\/497280","article-title":"MiR-126 is involved in vascular remodeling under laminar shear stress","volume":"2015","author":"Mondadori Dos Santos","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.vph.2015.09.003_bb0935","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2013.06.025","article-title":"Oxidative stress in atherosclerosis: the role of microRNAs in arterial remodeling","volume":"64","author":"Zampetaki","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0940","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2174\/0929867322666141128163739","article-title":"Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach","volume":"22","author":"Santilli","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.vph.2015.09.003_bb0945","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11883-013-0372-2","article-title":"Endothelial microRNAs and atherosclerosis","volume":"15","author":"Sun","year":"2013","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.vph.2015.09.003_bb0950","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0140-6736(13)62365-X","article-title":"Type 2 diabetes as a redox disease","volume":"383","author":"Watson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2015.09.003_bb0955","first-page":"556","article-title":"Oxidative stress and the unfulfilled promises of antioxidant agents","volume":"9","author":"Giorgio","year":"2015","journal-title":"E cancer med. sci."},{"key":"10.1016\/j.vph.2015.09.003_bb0960","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1089\/ars.2011.4414","article-title":"Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy","volume":"16","author":"Gupta","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.vph.2015.09.003_bb0965","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.freeradbiomed.2012.09.028","article-title":"Redox regulation of the epigenetic landscape in cancer: a role for metabolic reprogramming in remodeling the epigenome","volume":"53","author":"Hitchler","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.09.003_bb0970","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007653","article-title":"Antioxidants accelerate lung cancer progression in mice","volume":"6","author":"Sayin","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vph.2015.09.003_bb0975","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1503\/cmaj.051351","article-title":"Health benefits of physical activity: the evidence","volume":"174","author":"Warburton","year":"2006","journal-title":"Can. Med. Assoc. J."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115002049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115002049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T15:51:47Z","timestamp":1748620307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189115002049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":195,"alternative-id":["S1537189115002049"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2015.09.003","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidative stress in chronic vascular disease: From prediction to prevention","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2015.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2015.04.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}